Latest episodes

View all episodes
  • Bobby Sheng

    Bora Pharmaceuticals

    Episode 10

    Taking the family-owned CMO global

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng, CEO and Chairman of Bora Pharmaceuticals. A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from

    Read more
  • John Ross

    Mayne Pharma

    Episode 9

    The increasing demand for HPAPI

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013

    Read more
  • Michael Quirmbach

    Corden Pharma

    Episode 8

    A CDMO on the Covid-19 frontline

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and

    Read more
  • Eugene Ciolfi

    MedPharm

    Episode 7

    Learnings from 30 years in the CDMO space

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene

    Read more